Aditxt stock.
According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.
The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...A. While ratings are subjective and will change, the latest Aditxt ( ADTX) rating was a maintained with a price target of $4.00 to $61.00. The current price Aditxt ( ADTX) is trading at is $3.57 ...
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded warrant in lieu thereof) at a purchase price of $10.00 ... Aditxt Inc (ADTX) stock is trading at $14.75 as of 10:47 AM on Thursday, Sep 28, a rise of $1.71, or 13.15% from the previous closing price of $13.04. The stock has traded between $13.33 and $24.00 so far today. Volume today is low. So far 308,003 shares have traded compared to average volume of 419,078 shares. More About Aditxt Inc
Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …
Nov 15, 2023 · In conclusion, Aditxt Inc (ADTX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high. Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. Aditxt (NASDAQ:ADTX) filed a prospectus to the resale by selling stockholders of up to 264,516 shares of common stock. This prospectus is not an offer to sell. Filing Aditxt appoints Ernie Lee as ...Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Business Wire - Thu Apr 20, 12:35PM CDT . Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that...
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is ...
Aditxt®, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its innovation programs and strategic M&A initiatives. At …
Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. Find the latest Aditxt, Inc. (ADTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 4, 2023 · Aditxt Inc (NASDAQ: ADTX) has experienced a decline in its stock price by -14.36 compared to its previous closing price of 3.97. However, the company has seen a fall of -6.34% in its stock price over the last five trading days. InvestorPlace reported 2023-11-30 that Aditxt (NASDAQ: ADTX ) stock is rocketing higher on Thursday despite […] If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.RICHMOND, Va., August 31, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common stock (or pre-funded warrant in lieu thereof) at a purchase price of $10.00 ...
On April 3, 2023, Aditxt subsidiary, Pearsanta, Inc. (“Pearsanta”) submitted a bid to acquire substantially all of Lucira Health Inc.’s (“Lucira”) assets, which included Lucira Connect and FDA-approved at-home combination COVID-19 and flu tests. At the bankruptcy auction, which was held on April 6, 2023, Pearsanta was chosen as the ...Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,000,000 shares of common …17 Aug 2023 ... Aditxt®, Inc. (NASDAQ: ADTX) is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system ...Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... EBIT Margin. -2872.56%. -43865.44%. -. -. -. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Aditxt, Inc. (ADTX). See many years of revenue, …
Aditxt Inc. stock performance at a glance. Check Aditxt Inc. ’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. NASDAQ:ADTX - Aditxt Stock Price, News & Analysis S&P 500 4,550.43 DOW 35,333.47 QQQ Is Microsoft the NVIDIA Killer? [Investor Alert] Potential …
189,204 Yield ADTX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) Shares Sold Short 959 Change from Last 140.35% Percent of Float...Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern Time on August 18, 2023.RICHMOND, Va., April 20, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.What is Aditxt's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for Aditxt stock is Buy based on the current 1 buy rating for ADTX. The average twelve-month price prediction for Aditxt is $61.00 with a high price target of $61.00 and a low price target of $61.00.Find the latest analyst research for Aditxt, Inc. Common Stock (ADTX) at Nasdaq.com.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Stock Quote Charting
EBIT Margin. -2872.56%. -43865.44%. -. -. -. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Aditxt, Inc. (ADTX). See many years of revenue, …
Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...
Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ... Aditxt Inc. (NASDAQ:ADTX) up 34% on Thursday after it said it will effect a 1-for-40 reverse split of its common stock effective on August 18.Commencing with the opening of trading on Nasdaq on ...Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...ADiTx Therapeutics Stock Earnings. The value each ADTX share was expected to gain vs. the value that each ADTX share actually gained. ADiTx Therapeutics ( ADTX) reported Q2 2023 earnings per share (EPS) of -$36.79, beating estimates of -$115.60 by 68.18%. In the same quarter last year, ADiTx Therapeutics 's earnings per share (EPS) was -$256.80 ...Dec 1, 2023 · According to 1 stock analyst, the 12-month stock price forecast for Aditxt stock is $61, which predicts an increase of 1,694.12%. On average, analysts rate Aditxt stock as a strong buy. Aditxt stock drops 48% on $10M private placement msn.com - September 1 at 3:54 AM: Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules finance.yahoo.com - August 31 at 10:54 PM: What's Going On With Aditxt Stock Today benzinga.com - August 31 at 5:54 PM: marketbeat.com - August 31 at 3:57 …Aditxt, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Aditxt, Inc. Stock | ADTX | US0070256047Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. No new press releases or filings with the Securities and Exchange Commission (SEC ...Aditxt (NASDAQ:ADTX) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq ...Aditxt Inc is lower by Tuesday morning, with the stock declining -18.96% in pre-market trading to 33.52.ADTX's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market.
Aditxt, Inc. Stock price Equities ADTX US0070256047 Biotechnology & Medical Research Market Closed ... Nov 30, 2023 · The average price predicted for Aditxt Inc (ADTX) by analysts is $3.70, which is $0.03 above the current market price. The public float for ADTX is 0.19M, and at present, short sellers hold a 1.89% of that float. On November 30, 2023, the average trading volume of ADTX was 189.67K shares. ADTX) stock’s latest price […] What is Aditxt's Market Cap? ( NASDAQ: ADTX) Aditxt 's market cap is $2.03M, as of Oct 13, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Aditxt 's market cap is calculated by multiplying ADTX 's current stock price of $10.65 by ADTX 's total outstanding shares of 190,268.Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ... Instagram:https://instagram. who is america's richest persontencent holdings ltd stockcompanies going bankruptcies 2023pinnacle finacial partners Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company. nvda financialshow do i buy canadian stocks Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ... 1980 silver price Aditxt Inc ( ADTX) is up 11.47% today. ADTX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on ADTX! ADTX stock closed at $3.40 and is up $0.39 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.Aditxt Inc. stock performance at a glance. Check Aditxt Inc. ’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.